Skip to main content

Diabetes Mellitus (DM)

 

Diabetes Mellitus (DM)

    DM is a metabolic disease characterized by severe hyperglycemia

  Persistently high blood glucose level leads to various long term complications

    Diabetes is broadly divided into

  Insulin dependent diabetes mellitus (IDDM)

  Non-Insulin dependent diabetes mellitus (NIDDM)


i) Insulin dependent diabetes mellitus (IDDM)

    Also called type-I diabetes or juvenile onset diabetes

  Occurs in childhood (Between 12-15 years age)

  10-20% of total known DM patients

    Characterized by total deficiency of insulin

  Destruction of β-cells of islets of Langerhans caused by

    Autoimmunity

    Drugs

    Viruses

    Obesity

    Due to certain genetic variations β-cells are identified as foreign cells

Destroyed by immune mediated injury

    Symptoms appear when 80-90% of cells are lost

Pancreas fail to produce insulin in response to sugar ingestion

    Insulin therapy is needed for the treatment

ii) Non-insulin dependent diabetes mellitus (NIDDM)

    Also called type-II diabetes or maturity onset diabetes or adult onset diabetes

    Most common type of DM

  80 to 90 % of known patients

    Occurs in adults (above 30 to 35 Years of age)

  Less severe than type-I DM

    Causes are genetic, environmental and personal lifestyle based

  Particularly linked with obesity (diabetogenic factor)

    Decrease in insulin receptors on target cells

    Amount of insulin may either be normal or even elevated

    Many times weight loss alone is sufficient to treat it

Mostly oral hypoglycemic agents are needed to control blood sugar levels

    Recent studies shows insulin resistance is caused by

  Increased level of Tumor necrosis factor-α (TNF-α)

  Decreased secretions of adiponectin by adipocytes of obese people

    Normal glucose levels

    Fasting: >100mg/dL

    Random: >150mg/dL

Signs & Symptoms of uncontrolled DM

    Uncontrolled DM leads to the manifestation of the following signs & symptoms in patients:

  Hyperglycemia

  Glycosuria (Glucose in urine)

  Polyuria (Increased urination)

  Polydipsia (excessive drinking of water due to thirst)

  Polyphagia (Hyperphagia: increased food intake)

  Ketosis (Ketoacidosis)

  Loss of body weight (increased catabolism of fats & proteins)

  Water & electrolyte imbalance

  Hyperlipidemia (elevated lipids in blood; LDL,VLDL etc.)

 

    Severe and persistent hyperglycemia may cause

  Glucose toxicity

   Osmotic effects/hypertonic effects results in polyurea

   β-cell damage due to enhanced oxidative phosphorylation

   Increased glycation of proteins can be linked with Diabetes associated complications

  Atherosclerosis

  Gangrene

  Neuropathy, Nephropathy and Retinopathy, etc.

  Ketoacidosis

     Increased mobilization of fatty acids

   Overproduction of ketone bodies

   Hypertriglyceridemia and hypercholesterolemia

     Increased level of triglycerides, VLDL, chylomicrons and choleserol

Treatment of diabetes mellitus:

     Management option of DM includes

  Diet

   Low caloric, low carbohydrates, high protein and fiber rich diet should be taken

   Fat should be drastically reduced (unsaturated FA)

  Exercise

  Drugs and finally

   Oral hypoglycemic agents are used (Sulfonylureas & biguinides)

  Insulin (short acting & long acting (modified) insulin)

    Most cases can be controlled only by diet & exercise or drugs

  Only 20-30% patients need insulin

    Elevated glucose level should not be used as index for DM

    DM can be diagnosed on the basis of individual’s response to oral glucose load

  Oral glucose tolerance test

    10 Hours fasting blood and urine analysis

    75g Glucose is administered orally in 1 glass (300mL) water

    Continuous sampling every 30 minutes for 2 hours

 

    Other indices for DM management are:

  Random and Fasting BSL

   Most significant and easy detection of short term control can be estimated by Fasting and random BSL

  Glycosuria

   Most commonest cause of glycosuria is DM

  Glycated hemoglobin (HbA1C) (2-3 months control)

   Condensation of N-terminal valine of each β-chain with glucose 

   Conc. of HbA1C can also be used for diagnosis (>7%)

Comments

Popular posts from this blog

MEDICINAL CHEMISTRY Complete syllabus

    PHARMACEUTICAL CHEMISTRY-IV (MEDICINAL CHEMISTRY) (Theory) Paper 1                                                                                                                                                         ...

Melanocyte Stimulating Hormone (MSH)

    Melanocyte Stimulating Hormone (MSH) •     Secreted by Pars inermedia (intermediate lobe) of pituitary •     Occurs in three different forms (α, β, and γ MSH) •     Biosynthesis: – MSH is the cleavage product of a large precursor peptide called pro-opiomelano cortin (POMC) •     Protease enzyme cleave POMC into ACTH and βlipotropin •     ACTH is further cleaved to form MSH   •     Mechanism: •     Act by binding the G-protein coupled melanocortin 1 receptor (MC1R) on melanocytes – Increases cAMP levels through adenylyl cyclase •     Functions of MSH: •     Stimulate the production and release of melanin from melanocytes in skin & hair (melanogenesis) –   Darkens the skin •     α-MSH acts on hypothalamus –   Suppresses appetite –   Arouse sexually     ...

Adrenocorticotropin

   Adrenocorticotropin •     Also called Adrenocorticotropic Hormone (ACTH) , corticotropin •     Concerned with the growth and functioning of adrenal cortex •     Chemistry: – Single polypeptide with 39 aminoacids •     First 23 amino acids from N-terminal contains biological activity –   Molecular weight 4500 –   Occurs in two forms •      α-corticotropin •      β-corticotropin •      ACTH is synthesized from a glycoprotein called Proopiomelano cortin (POMC) peptide •      POMC is hydrolyzed by different enzymes to form: –   ACTH –   β-Lipotropin –   β-Endorphins  –   Melanocyte Stimulating Hormone (MSH) etc. •     Mechanism of Action •     Ca 2+ ion dependant activation of cAMP – Increased transcription and translation •  ...